DarioHealth Corp DRIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
-
Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy
-
Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships
-
Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform
-
Dario More Than Doubles Addressable Market in Solera Health's Network via Expanded Hypertension Program, With Dario Now Reaching Greater Than 500,000 Eligible Lives
-
DarioHealth Reports First Quarter 2026 Financial and Operating Results
-
DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026
-
Dario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative Research
Trading Information
- Previous Close Price
- $7.22
- Day Range
- $6.88–7.19
- 52-Week Range
- $5.84–17.74
- Bid/Ask
- $5.50 / $7.88
- Shares Outstanding
- 7.31M
- Market Cap
- $51.19M
- Volume/Avg
- 2,729 / 11,492
Key Statistics
- Price/Earnings (Normalized)
- 1.13
- Price/Sales
- 1.68
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 165
- Website
- https://www.mydario.com
Valuation
|
Metric
|
DRIO
|
|---|---|
Price/Earnings (Normalized) | 1.13 |
Price/Book Value | 0.83 |
Price/Sales | 1.68 |
Price/Cash Flow | — |
Price/Earnings
DRIO
Financial Strength
|
Metric
|
DRIO
|
|---|---|
Quick Ratio | 2.60 |
Current Ratio | 3.07 |
Interest Coverage | −13.77 |
Quick Ratio
DRIO
Profitability
|
Metric
|
DRIO
|
|---|---|
Return on Assets (Normalized) | −31.52% |
Return on Equity (Normalized) | −51.01% |
Return on Invested Capital (Normalized) | −32.81% |
Return on Assets
DRIO
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|Q^C!XNQ | LOCK|<v> | $31B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|Y<nV | $15B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|sT^<w | $15B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|KD@<Q | $14B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|wG | $11B | |||
| HealthEquity Inc
HQY
| — | LOCK|sl&F! | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|&ZP!! | $8B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|SW# | $7B | |||
| 10x Genomics Inc Ordinary Shares - Class A
TXG
| — | LOCK|!@ | $5B | |||
| Waystar Holding Corp
WAY
| — | LOCK|%? | $4B |
United States